Cargando…

Pathogenic Role of MicroRNA Dysregulation in Podocytopathies

MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrot...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feng, Chen, Jiefang, Luo, Changqing, Meng, Xianfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277480/
https://www.ncbi.nlm.nih.gov/pubmed/35845986
http://dx.doi.org/10.3389/fphys.2022.948094
_version_ 1784745991359954944
author Liu, Feng
Chen, Jiefang
Luo, Changqing
Meng, Xianfang
author_facet Liu, Feng
Chen, Jiefang
Luo, Changqing
Meng, Xianfang
author_sort Liu, Feng
collection PubMed
description MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease.
format Online
Article
Text
id pubmed-9277480
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92774802022-07-14 Pathogenic Role of MicroRNA Dysregulation in Podocytopathies Liu, Feng Chen, Jiefang Luo, Changqing Meng, Xianfang Front Physiol Physiology MicroRNAs (miRNAs) participate in the regulation of various important biological processes by regulating the expression of various genes at the post-transcriptional level. Podocytopathies are a series of renal diseases in which direct or indirect damage of podocytes results in proteinuria or nephrotic syndrome. Despite decades of research, the exact pathogenesis of podocytopathies remains incompletely understood and effective therapies are still lacking. An increasing body of evidence has revealed a critical role of miRNAs dysregulation in the onset and progression of podocytopathies. Moreover, several lines of research aimed at improving common podocytopathies diagnostic tools and avoiding invasive kidney biopsies have also identified circulating and urine miRNAs as possible diagnostic and prognostic biomarkers for podocytopathies. The present review mainly aims to provide an updated overview of the recent achievements in research on the potential applicability of miRNAs involved in renal disorders related to podocyte dysfunction by laying particular emphasis on focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous nephropathy (MN), diabetic kidney disease (DKD) and IgA nephropathy (IgAN). Further investigation into these dysregulated miRNAs will not only generate novel insights into the mechanisms of podocytopathies, but also might yield novel strategies for the diagnosis and therapy of this disease. Frontiers Media S.A. 2022-06-29 /pmc/articles/PMC9277480/ /pubmed/35845986 http://dx.doi.org/10.3389/fphys.2022.948094 Text en Copyright © 2022 Liu, Chen, Luo and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Liu, Feng
Chen, Jiefang
Luo, Changqing
Meng, Xianfang
Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title_full Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title_fullStr Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title_full_unstemmed Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title_short Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
title_sort pathogenic role of microrna dysregulation in podocytopathies
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277480/
https://www.ncbi.nlm.nih.gov/pubmed/35845986
http://dx.doi.org/10.3389/fphys.2022.948094
work_keys_str_mv AT liufeng pathogenicroleofmicrornadysregulationinpodocytopathies
AT chenjiefang pathogenicroleofmicrornadysregulationinpodocytopathies
AT luochangqing pathogenicroleofmicrornadysregulationinpodocytopathies
AT mengxianfang pathogenicroleofmicrornadysregulationinpodocytopathies